Home › Funds › OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM › CDTX

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM position in CDTX

CIDARA THERAPEUTICS INC

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM reported holding 315,474 shares of CDTX (CIDARA THERAPEUTICS INC) in its Q4 2025 13F filing — a position valued at US$69.7M, representing 1.95% of its reported portfolio and ranking #13 among its reported holdings. OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM first reported this position in Q4 2025.

Latest position (Q4 2025)315.47K sh
Reported value held$69.69M
Portfolio Weight1.95%
First reportedQ4 2025
Last changeNew
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's CDTX position evolved

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM first disclosed a stake in CDTX in Q4 2025 at 315,474 shares (US$69.7M).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 315.47K $69.69M New

About CDTX and 13F data

CDTX (CIDARA THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 1 other funds we track also report a position in CDTX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CDTX

No other tracked fund reports a position in CDTX.

All CDTX fund holders →

FAQ

How long has OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM held CDTX?

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM has disclosed CDTX holdings in 1 of the last 1 reported quarters, going back to Q4 2025.

What is OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's current position in CDTX?

As of Q4 2025, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM holds 315.47K shares of CDTX (CIDARA THERAPEUTICS INC), valued at $69.69M, representing 1.95% of its reported portfolio and ranking #13.

Has OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM been buying or selling CDTX?

In the latest 13F filing (Q4 2025), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM newly opened its position in CDTX.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.